Related Experiment Video
Updated: Dec 31, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Overview of managing medical comorbidities in patients with severe mental illness
1Department of Psychiatry and Pharmacology, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
Insights
Patients with severe mental disorders face higher mortality, primarily from cardiovascular disease (CVD). Addressing obesity and metabolic issues through integrated care and weight management is crucial for this population.
Area of Science:
- Psychiatry and Cardiology
- Public Health
- Metabolic Disorders
Background:
- Severe mental disorders are linked to increased mortality rates compared to the general population.
- Cardiovascular disease (CVD) is the leading cause of death for individuals with psychotic illnesses or bipolar disorder.
- Comorbidities like obesity, metabolic syndrome, and diabetes exacerbate CVD risk in this population due to factors including medication side effects and lifestyle challenges.
Purpose of the Study:
- To highlight the significant burden of cardiovascular disease (CVD) in patients with severe mental illness.
- To identify the contributing factors to higher CVD rates in this demographic.
- To propose strategies for mitigating CVD risk in individuals with mental health conditions.
Main Methods:
- Review of existing literature on mortality rates in severe mental illness.
- Analysis of the relationship between psychiatric disorders and cardiovascular risk factors.
- Examination of treatment modalities for managing comorbid physical health conditions.
Main Results:
- Cardiovascular disease is the primary cause of premature death in patients with severe mental disorders.
- Obesity, metabolic syndrome, and diabetes are prevalent and contribute to worse CVD outcomes.
- Inadequate healthcare access, lifestyle factors, and antipsychotic medication side effects compound these risks.
Conclusions:
- Integrated care models combining psychiatric and somatic treatments are essential.
- Weight-neutral or weight-reducing medications may help manage medication-induced weight gain.
- Behavioral weight management programs offer a viable strategy to reduce CVD burden in the mental health population.
Abstract:
Patients with severe mental disorders have increased mortality rates compared with the general population. The leading cause of death for individuals with psychotic illnesses or bipolar disorder is cardiovascular disease (CVD), which is often the result of patients' health problems associated with their psychiatric disorders, including, but not limited to, obesity, metabolic syndrome, and diabetes. Such problems occur more often and have worse outcomes in patients with serious mental illness than the general population because of a combination of factors such as inadequate access to quality care, poor lifestyle choices, and the association between some antipsychotic medications and weight gain. Coordinated somatic and psychiatric treatment, weight-neutral or weight-reducing pharmaceuticals, and behavioral weight management programs may help lessen the burden of CVD in the mental health population.
More Related Videos
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment